Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Microtransplantation for AML
NCT04174586Phase 1Unknown
- Sponsor
- 307 Hospital of the People's Liberation Army
- Start
- Jan 2020
- Primary completion
- Aug 2024
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of umbilical cord blood in acute myeloid leukemia (AML), sponsored by 307 Hospital of the People's Liberation Army. Primary endpoints: Complete Remission Rate at 1 month and Time of Hematopoietic Recovery at 1 month. Status: unknown.
02
Drugs
umbilical cord blood
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT04174586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04174586.